BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  NSCLC Drug Improves Progression-Free Survival in Late-Stage Trial

  Junshi Biosciences announced that the Phase III clinical trial it is conducting alongside Coherus BioSciences on a potential non-small cell lung cancer drug shows positive preliminary results.

  August 19, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Ginkgo Boasts Banner Year with Collabs, Breakthroughs and SPAC Deal

  Ginkgo has signed multiple collaborations, announced a breakthrough in manufacturing mRNA vaccine components, and landed an SPAC deal.

  August 19, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Employer Resources

  As Delta Variant Surges, More Biopharma Companies Mandate COVID-19 Vaccines

  Fueled by the highly contagious delta variant, life science companies have issued policies on COVID-19 vaccines, including verbiage around exemptions or solutions for medical objections.

  August 19, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Business

  BioSpace Movers & Shakers, Aug. 20

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  August 19, 2021

   · 

  8 min read

   · 

  Alex Keown
• 

  Policy

  COVID-19 Boosters Get Official Guidance, Critics Sound Dissent

  The decision is largely based on three studies.

  August 19, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  BioCapital

  Research Roundup: Preventing Type 1 Diabetes and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  August 19, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Pharm Country

  Seqirus Forms Dedicated sa-mRNA Program, Taps In-House R&D Head to Oversee

  New Jersey-based Seqirus is expanding and accelerating its capabilities to develop next-generation self-amplifying mRNA (sa-mRNA) vaccines for influenza and other viral illnesses.

  August 19, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Researchers Demonstrate Ways to Improve CAR-T for Solid Tumors

  Researchers with the Georgia Institute of Technology recently published work that describes several new approaches to improving CAR-T, particularly for solid tumors.

  August 19, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Canada Gaining in the Global War for Biotech Talent

  Toronto saw the biggest growth in technology jobs of any North American city between 2015 and 2020, while Vancouver, British Columbia also made the top five.

  August 19, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Biotech Company Earns Two Patents for Targeted Delivery of Psychedelic Meds

  Psycheceutical Inc. was issued two patents by the United States Patent and Trademark Office for what it calls a “precision duplicity” approach to delivering psychedelic drugs to patients.

  August 19, 2021

   · 

  4 min read

   · 

  Gail Dutton